Loading...
Emcure Pharmaceuticals Limited — Ritonavir Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Ritonavir · $5.9M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #4 Indian exporter of Ritonavir with $5.9M in export value and 110 verified shipments. Emcure Pharmaceuticals Limited holds a 1.6% market share in Ritonavir exports across 43 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $550.0K | 11 | 13.6% |
| KENYA | $406.7K | 12 | 10.1% |
| MYANMAR | $350.0K | 7 | 8.7% |
| ZIMBABWE | $300.0K | 6 | 7.4% |
| ETHIOPIA | $250.0K | 5 | 6.2% |
| BURUNDI | $200.0K | 4 | 5.0% |
| MOZAMBIQUE | $200.0K | 4 | 5.0% |
| OMAN | $189.7K | 11 | 4.7% |
| SIERRA LEONA | $150.0K | 3 | 3.7% |
| NAMIBIA | $144.1K | 4 | 3.6% |
Emcure Pharmaceuticals Limited exports Ritonavir to 45 countries. The largest destination is SOUTH AFRICA accounting for 13.6% of Emcure Pharmaceuticals Limited's Ritonavir shipments, followed by KENYA (10.1%) and MYANMAR (8.7%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNITED NATIONS OFFICE FOR PROJECT | MYANMAR | $300.0K | 6 |
| EMCURE PHARMACEUTICALS SA (PTY) LTD | SOUTH AFRICA | $300.0K | 6 |
| MINISTRY OF HEALTH AND CHILD CARE | ZIMBABWE | $300.0K | 6 |
| ETHIOPIAN PHARMACEUTICAL SUPPLY SER | ETHIOPIA | $250.0K | 5 |
| PROGRAMME DES NATIONS UNIES POUR LE | BURUNDI | $200.0K | 4 |
| NATIONAL MEDICAL STORES |
India exported $69.2M worth of Ritonavir through 1,555 shipments from 84 suppliers to 155 countries, serving 525 buyers globally. Emcure Pharmaceuticals Limited contributes $5.9M to this total, accounting for 1.6% of India's Ritonavir exports. Emcure Pharmaceuticals Limited ships Ritonavir to 45 countries through 57 buyers.
Emcure Pharmaceuticals Limited's average Ritonavir shipment value is $53.6K per consignment, based on 110 shipments totaling $5.9M. The largest destination is SOUTH AFRICA (13.6% of Emcure Pharmaceuticals Limited's Ritonavir exports).
Emcure Pharmaceuticals Limited ranks #4 among 84 Indian Ritonavir exporters with a 1.6% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($27.5M), HETERO LABS LIMITED ($24.7M), EMCURE PHARMACEUTICALS LIMITED ($5.5M). Emcure Pharmaceuticals Limited processed 110 shipments to 43 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - ATAZOR R 300/100MG TABLET 30S WTC( ATAZANAVIR & RITONAVIR USP TABLETS 300 | $300.0K | 6 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS):- RITOATAZ 300/100 MG TABLET 30S ( ATAZANAVIR & RITONAVIR USP TABLETS 300/100MG | $300.0K | 6 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM : ATAZOR R 300/100MG TABLET 30S ATAZANAVIR & RITONAVIRTABLETS 300/100MG | $200.0K | 4 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS)- ATAZOR R 300/100MG TABLET 30S WTC ( ATAZANAVIR & RITONAVIR USP TABLETS 300/10 | $200.0K | 4 |
| PHARMACEUTICALS PRODUCTS (FINISHED PRODUCT GENERIC NAME) ATAZOR R 300/100MG TABLET 30S WTC ( ATAZANAVIR & RITONAVIR USPPCS | $150.0K | 3 |
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) RITOATAZ 300/100 MG TABLET 30S (ATAZANAVIR & RITONAVIR USP TABLETS 300/NOS | $150.0K | 3 |
| ATAZOR R 300/100MG TABLET 30S WTC (ATAZANAVIR & RITONAVIR USP TABLETS 300/100MG), Pack Size 1 X 30 |
What Emcure Pharmaceuticals Limited must comply with to export Ritonavir to its top destination countries
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MYLAN LABORATORIES LIMITED | $27.5M | 550 | 92 | $50.0K |
| 1 | HETERO LABS LIMITED | $24.7M | 494 | 81 | $50.0K |
| 4 | EMCURE PHARMACEUTICALS LIMITED ★ | $5.5M | 110 | 43 | $50.0K |
| 5 | AUROBINDO PHARMA LTD | $4.9M | 104 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 335 | 21.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 281 | 18.1% |
| HYDERABAD ACC (INHYD4) | 217 | 14.0% |
| HYDERABAD AIR | 123 | 7.9% |
| Bombay Air | 87 | 5.6% |
| NHAVA SHEVA SEA (INNSA1) | 58 | 3.7% |
| DELHI AIR CARGO ACC (INDEL4) | 48 | 3.1% |
| HYDERABAD ICD | 47 | 3.0% |
Emcure Pharmaceuticals Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Ritonavir, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ritonavir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Ritonavir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
| KENYA |
| $200.0K |
| 4 |
| UNITED NATIONS DEVELOPMENT PROGRAMM | PAKISTAN | $192.1K | 4 |
| MUSCAT PHARMACY & STORE LLC | OMAN | $185.4K | 10 |
| NATIONAL HIV/AIDS CONTROL PROGRAM | SIERRA LEONA | $150.0K | 3 |
| EMCURE PHARMACEUTICALS SA (PTY) LIMITED | SOUTH AFRICA | $150.0K | 3 |
Emcure Pharmaceuticals Limited supplies Ritonavir to 57 buyers globally. The largest buyer is UNITED NATIONS OFFICE FOR PROJECT (MYANMAR), followed by EMCURE PHARMACEUTICALS SA (PTY) LTD (SOUTH AFRICA) and MINISTRY OF HEALTH AND CHILD CARE (ZIMBABWE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $150.0K |
| 3 |
| PHARMACEUTICAL PRODUCTS FINISHED GOODS ATAZOR R 300 100 MG TABLET 30S ATAZANAVIR RITONAVIR TABLETS 300 100MG | $100.0K | 2 |
| ATAZOR R 300 100MG TABLETS ATAZANAVIR 300MG RITONAVIR USP 100MG 1x30TABS INV NO 2302100441 DT 22 02 2023 1PAC 1NO | $100.0K | 2 |
| ATAZOR R 300/100MG TABLETS ATAZANAVIR 300MG + RITONAVIR USP 100MG-1x30TABSINV.NO.2309100166 DT. 05.09.20231PAC=1NO | $100.0K | 2 |
Emcure Pharmaceuticals Limited exports 79 distinct Ritonavir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - ATAZOR R 300/100 with 6 shipments worth $300.0K.
| 39 |
| $47.0K |
| 7 | AUROBINDO PHARMA LIMITED | $2.1M | 43 | 26 | $50.0K |
Emcure Pharmaceuticals Limited ranks #4 among 84 Indian Ritonavir exporters. Average shipment value of $50.0K compared to the market average of $823.4K. The closest competitors by value are MYLAN LABORATORIES LIMITED and HETERO LABS LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 155+ countries, 525+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ritonavir. For current shipment-level data, contact TransData Nexus.